Trial Profile
A retrospective study comparing renal efficacy and safety of telbivudine, entecavir and tenofovir disoproxil fumarate treatment in chronic hepatitis B patients: a real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2017 New trial record